Table 6.
Measure/Modela | Overall | Serious Fall Injurya | |
---|---|---|---|
No | Yes | ||
No. of patients | 37,752 | 35,808 | 1944 |
No. of patients transplanted | 8924 | 8638 | 286 |
Total patient-yr | 67,978.9 | 63,020.6 | 4958.3 |
Transplant rate per 100 patient-yr | 13.1 | 13.7 | 5.8 |
Hazard ratios for waitlisting by serious fall injury (95% CI) | |||
Primary analyses | |||
Crude | 1.00 (Reference) | 0.77 (0.68 to 0.87) | |
Adjusted, demographicsb | 1.00 (Reference) | 0.73 (0.65 to 0.82) | |
Adjusted, demographics + clinicalb | 1.00 (Reference) | 0.71 (0.63 to 0.80) | |
Sensitivity analysesc | |||
Additional adjustment for | |||
Dialysis modality | 1.00 (Reference) | 0.71 (0.63 to 0.80) | |
Peripheral vascular disease | 1.00 (Reference) | 0.71 (0.63 to 0.80) | |
Amputation | 1.00 (Reference) | 0.71 (0.63 to 0.80) | |
Inability to walk | 1.00 (Reference) | 0.71 (0.63 to 0.80) | |
Inability to transfer | 1.00 (Reference) | 0.71 (0.63 to 0.80) | |
Institutionalization | 1.00 (Reference) | 0.71 (0.63 to 0.80) | |
Fall injuries with E codes only | 1.00 (Reference) | 0.68 (0.54 to 0.87) | |
Among those with no fall injuries before waitlisting | 1.00 (Reference) | 0.70 (0.62 to 0.79) | |
Subgroup analysesc | |||
Age, yr | |||
18–39 | 1.00 (Reference) | 0.62 (0.47 to 0.81) | |
40–64 (P40–64×18–39=0.47) | 1.00 (Reference) | 0.74 (0.64 to 0.86) | |
≥65 (P≥65×18–39=0.85) | 1.00 (Reference) | 0.68 (0.52 to 0.90) | |
Sex | |||
Men | 1.00 (Reference) | 0.68 (0.58 to 0.81) | |
Women (Pwomen×men=0.61) | 1.00 (Reference) | 0.74 (0.62 to 0.87) | |
Race/ethnicity | |||
Non-Hispanic white | 1.00 (Reference) | 0.65 (0.56 to 0.77) | |
Black (Pblack×white=0.11) | 1.00 (Reference) | 0.80 (0.63 to 1.02) | |
Hispanic white (PHispanic×white=0.56) | 1.00 (Reference) | 0.78 (0.58 to 1.05) | |
Other (Pother×white=0.35) | 1.00 (Reference) | 0.83 (0.49 to 1.38) |
n=37,164 for models. 95% CI, 95% confidence interval.
From cohort entry to outcome or censoring.
Demographics: age, sex, and race/ethnicity. Clinical: body mass index, dialysis vintage, comorbid diabetes, ischemic heart disease, and hypertension.
Using the fully adjusted (demographics + clinical) model.